SS Innovations Expands Global Opportunity with Regulatory Approval of the SSi Mantra Surgical Robotic System in Colombia, Oman, Sri Lanka and Kenya

Core Viewpoint - SS Innovations International, Inc. has received regulatory approval for its SSi Mantra surgical robotic system in multiple countries, aiming to enhance access to robotic surgery globally [1][2][3] Regulatory Approvals - The SSi Mantra received regulatory approval from INVIMA in Colombia and DGPA&DC in Oman in November 2025, and from NMRA in Sri Lanka and PPB in Kenya in January 2026 [2] - The company has now achieved regulatory approval in eleven countries, including India [3] Market Positioning - SS Innovations is strategically positioned to penetrate underdeveloped markets due to the SSi Mantra's cost advantages, advanced technology, and user-friendly features [2] - The company aims to democratize access to robotic surgery in underserved regions while also pursuing established markets in the U.S. and European Union [3] Product Overview - The SSi Mantra is a modular, multi-arm surgical robotic system featuring advanced technology such as 3 to 5 robotic arms, a 3D 4K monitor, and a portable Tele Surgeon Console for enhanced flexibility [6][8] - The system supports over 40 types of robotic endo-surgical instruments, catering to various specialties including cardiac and pediatric surgeries [8] Surgical Performance - As of December 31, 2025, the SSi Mantra has an installed base of 168 units across ten countries, with a total of 7,885 surgeries performed, including 390 cardiac procedures and 121 pediatric surgeries [4]